Defibrillator News and Research RSS Feed - Defibrillator News and Research

An implantable cardioverter defibrillator (ICD) is a small device that's placed in your chest or abdomen. This device uses electrical pulses or shocks to help control life-threatening, irregular heartbeats, especially those that could lead the heart to suddenly stop beating (sudden cardiac arrest). If the heart stops beating, blood stops flowing to the brain and other vital organs. This usually causes death if it's not treated in minutes.
State highlights: Texas immigrant surge brings health crisis

State highlights: Texas immigrant surge brings health crisis

Large stores in California need not keep automated external defibrillators for customers who suffer heart attacks, the California Supreme Court decided. In a unanimous ruling Monday, the state's highest court said California law requires only that fitness centers have such potentially life-saving devices and encourages most public buildings to keep them (Dolan, 6/23). [More]
First Edition: June 24, 2014

First Edition: June 24, 2014

Today's headlines include news about the latest report detailing problems at the VA. [More]
Cardiac Lead Extraction celebrates 25-Year anniversary at Cardiostim

Cardiac Lead Extraction celebrates 25-Year anniversary at Cardiostim

A quarter century ago, doctors treating patients with implanted cardiac pacemakers had a big problem. Their patients were outliving the complex electrical devices that gave them an acceptable quality of life. [More]
New legislation allows Illinois high schools to add CPR and AED training to curriculum

New legislation allows Illinois high schools to add CPR and AED training to curriculum

Illinois firefighters and advocates from the American Heart Association applauded Governor Quinn for signing House Bill 3724 into law at the annual Associated Fire Fighters of Illinois convention in Bloomington-Normal. [More]
NYU Langone Medical Center implants RNS device in brain for patients with epilepsy

NYU Langone Medical Center implants RNS device in brain for patients with epilepsy

NYU Langone Medical Center last month became the first hospital outside of a clinical trial site to implant a pacemaker-like device in the brain that may be a game-changer for patients with epilepsy. [More]
ICD, CRT-D patients benefit to almost equivalent extent from home telemonitoring

ICD, CRT-D patients benefit to almost equivalent extent from home telemonitoring

Home telemonitoring is equally effective in ICD and CRT-D patients, a subanalysis of the IN-TIME trial has shown. [More]

St. Jude Medical presents new data on quadripolar technology at Heart Rhythm 2014

St. Jude Medical, Inc., a global medical device company, is the leader in quadripolar technology with the only cardiac resynchronization therapy (CRT) system approved in the U.S. New data presented at Heart Rhythm 2014, the Heart Rhythm Society's Annual Scientific Sessions, demonstrates increased survival, improved clinical outcomes and better cost utilization with St. Jude Medical's quadripolar technology. [More]
Loyola offers new type of implantable defibrillator that prevents sudden cardiac death

Loyola offers new type of implantable defibrillator that prevents sudden cardiac death

Loyola University Medical Center has begun offering patients a new type of implantable defibrillator that prevents sudden cardiac death with an electric shock to the heart. [More]
Cook Medical's Instinct Endoscopic Hemoclip now available to gastroenterologists

Cook Medical's Instinct Endoscopic Hemoclip now available to gastroenterologists

The Instinct Endoscopic Hemoclip is now available to gastroenterologists in major global markets. The clip is used to stop gastrointestinal (GI) tract bleeding, which is a condition that can be challenging to treat because of the variations among bleeds. [More]

St. Jude Medical's net sales increase 2% in first quarter 2014

St. Jude Medical, Inc. today reported sales and net earnings for the first quarter ended March 29, 2014. [More]

Boston Scientific to launch of S-ICD System into parts of Asia

Boston Scientific Corporation (NYSE: BSX) has expanded the launch of its S-ICD System into parts of Asia. The first implant of the S-ICD System in Asia was performed in Hong Kong by Prof. Hung Fat Tse, Professor of Cardiovascular Medicine, The University of Hong Kong and Department of Medicine, Queen Mary Hospital in Pokfulam, Hong Kong, under the proctorship of Dr. Martin Stiles, Director of Electrophysiology, Waikato Hospital in Hamilton, New Zealand. [More]
Arnold Palmer Hospital cardiologists perform Florida's first pediatric implant of new device to prevent sudden cardiac arrest

Arnold Palmer Hospital cardiologists perform Florida's first pediatric implant of new device to prevent sudden cardiac arrest

Cardiologists at Arnold Palmer Hospital for Children today performed Florida's first pediatric implant of a new device to prevent sudden cardiac arrest. [More]
Researcher finds simple blood test that predicts person's risk for sudden cardiac death

Researcher finds simple blood test that predicts person's risk for sudden cardiac death

A researcher at the Cardiovascular Institute (CVI) at Rhode Island, The Miriam and Newport hospitals has found that a simple blood test can predict a person's risk for sudden cardiac death, enabling physicians to more quickly and accurately assess a patient's need for an implantable cardiac defibrillator (ICD). [More]
Boston Scientific presents new data on cardiology-related clinical trials at ACC 2014

Boston Scientific presents new data on cardiology-related clinical trials at ACC 2014

Reinforcing its position as a global leader in bringing new therapies to patients with heart and cardiovascular disease, Boston Scientific Corporation (NYSE: BSX) reported favorable results in studies related to cardiac resynchronization therapy (CRT), platinum chromium stent platforms and transcatheter aortic valve replacement (TAVR). [More]
Cheap drug holds promise of treating heart attack patients

Cheap drug holds promise of treating heart attack patients

​The initial results of this trial were published a few months ago (Circulation. 2013;128:1495-1503), and showed that patients who received this treatment during emergency transit to hospital had much smaller amounts of dead heart muscle than those randomly assigned to receive no treatment. [More]

MADIT-CRT study: Boston Scientific CRT defibrillator reduces risk of death in mild heart failure patients

In the longest follow-up to date of cardiac resynchronization therapy (CRT) for mild heart failure patients, Boston Scientific Corporation's exclusively sponsored and landmark Multicenter Automatic Defibrillator Implantation Trial – Cardiac Resynchronization Therapy (MADIT-CRT) study demonstrated significant and sustained survival benefit for the indicated population. [More]
Stem cell therapy may benefit patients with debilitating heart failure

Stem cell therapy may benefit patients with debilitating heart failure

Researchers want to know whether patients with debilitating heart failure can benefit by having their own stem cells injected into their ailing heart muscle. [More]
FDA approves expansion of BIOTRONIK's ongoing ProMRI trial

FDA approves expansion of BIOTRONIK's ongoing ProMRI trial

BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration has approved the expansion of BIOTRONIK's ongoing ProMRI trial. The new phase of the trial (Phase C) will study the company's ProMRI technology in implantable cardioverter-defibrillator (ICD) devices. [More]
Scientists throw light on genetic mutation that causes particularly severe genetic disease ARVC5

Scientists throw light on genetic mutation that causes particularly severe genetic disease ARVC5

The genetic disease ARVC leads to sudden cardiac death and is more common than it has been hitherto assumed. This is reported by an international team of researchers headed by Prof Dr Hendrik Milting from the Heart and Diabetes Center NRW in the "European Heart Journal". [More]
Scientists throw light on genetic mutation that causes ARVC5 in Newfoundland

Scientists throw light on genetic mutation that causes ARVC5 in Newfoundland

Scientists have thrown light on the genetic mutation that causes a particularly severe genetic disease (ARVC5) on the Canadian island Newfoundland in 2008. [More]